TRS

NEUTRAL

$38.27 Live

TriMas Corporation · NASDAQ

Target $45.0 (+17.6%)

$19.98 52W Range $42.0

TRS TriMas Corporation - Fundamental Analysis

NEUTRAL

Console Chart News

TRS Stock | Fundamental Analysis & Investment Insights

NASDAQ • Consumer Cyclical • Packaging & Containers

Current Price Live

$38.27

Analyst Target

$45.0

+17.6% Upside

52W High

$42.0

52W Low

$19.98

Overview AI Snowflake Price Valuation Profitability Growth Health Statements Peers Insiders SEC Filings

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 21, 2026

Market cap

$1.44B

P/E

21.5

ROE

10.5%

Profit margin

18.6%

Debt/Equity

0.74

Dividend yield

0.42%

AI Analysis

AI-powered fundamental assessment

Confidence

80%

TriMas Corporation presents a contradictory profile with a stable Piotroski F-Score of 4/9 and a strong 1-year price return of 90%, yet it suffers from severe fundamental deterioration. While the company maintains a healthy Debt/Equity ratio (0.74) and strong liquidity (Current Ratio 2.52), the massive YoY revenue decline of -31.80% and a negative operating margin (-3.38%) are critical concerns. The discrepancy between the Graham Number ($27.40) and the Intrinsic Value ($52.51) suggests the market is pricing in a recovery that is not yet supported by top-line growth. Overall, the stock is a speculative hold until revenue stabilizes.

Key Strengths

Strong liquidity position with a Current Ratio of 2.52

Manageable leverage with Debt/Equity at 0.74, below sector average

Positive net profit margin (18.61%) significantly outperforming sector peers

Consistent history of beating earnings estimates (3 of last 4 quarters)

Low dividend payout ratio (8.99%) providing ample room for future increases

Key Risks

Severe revenue contraction (-31.80% YoY and -161.38% Q/Q)

Negative operating margin (-3.38%) indicating core business inefficiency

Low Piotroski F-Score (4/9) suggesting mediocre financial health

Extreme volatility in earnings growth, likely due to low-base effects or one-time items

Bearish technical trend score (10/100) despite recent price appreciation

AI Fair Value Estimate

Based on comprehensive analysis

$36.5

-4.6% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall

Moderate

Value

Future

Past

Health

Dividend

AI Verdict

Speculative/Fragile

Key drivers: Revenue collapse, Operating margin deficit, Strong balance sheet liquidity

Confidence

85%

Value

55/100

Ref P/E, PEG, Graham Number

Positives

P/E (21.50) is lower than sector average (33.60)

Watchpoints

Current price exceeds Graham Number ($27.40)
PEG ratio of 1.94 suggests overvaluation relative to growth

Future

30/100

Ref Growth rates

Positives

Forward P/E (18.40) suggests expected earnings improvement

Watchpoints

Catastrophic YoY revenue growth (-31.80%)
Negative Q/Q revenue growth

Past

65/100

Ref Historical trends

Positives

Impressive 1-year price return of +90%
Consistent earnings beats over the last 4 quarters

Watchpoints

Recent Q/Q EPS growth decline (-34.4%)

Health

50/100

Ref Altman Z-Score, Piotroski F-Score

Positives

Low Debt/Equity (0.74)
High Current Ratio (2.52)

Watchpoints

Piotroski F-Score of 4/9 is only marginally stable
Very low ROA (0.83%)

Dividend

25/100

Ref Yield, Payout

Positives

Very low payout ratio (8.99%)

Watchpoints

Negligible dividend yield (0.42%)
Low dividend strength score (25/100)

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price

$38.27

Analyst Target

$45.0

Upside/Downside

+17.6%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for TRS and closest competitors.

Updated 2026-04-20

Company	5Y	3Y	1Y	6M	1M	1W
TRS TriMas Corporation Primary	+27.2%	+44.6%	+90.0%	+1.4%	+12.4%	-1.5%
REAL The RealReal, Inc. Peer	-47.8%	+923.7%	+124.5%	+17.7%	+28.0%	+24.7%
BH Biglari Holdings Inc. Peer	+310.2%	+205.9%	+110.4%	+46.2%	+29.3%	+1.5%
BH-A Biglari Holdings Inc. Peer	+361.4%	+231.2%	+131.1%	+55.9%	+29.8%	+2.3%
OLPX Olaplex Holdings, Inc. Peer	-91.7%	-47.8%	+63.2%	+65.8%	+63.2%	+0.5%

TRS

TriMas Corporation

Primary

+27.2%

+44.6%

+90.0%

+1.4%

+12.4%

-1.5%

REA

The RealReal, Inc.

Peer

-47.8%

+923.7%

+124.5%

+17.7%

+28.0%

+24.7%

Biglari Holdings Inc.

Peer

+310.2%

+205.9%

+110.4%

+46.2%

+29.3%

+1.5%

BH-

Biglari Holdings Inc.

Peer

+361.4%

+231.2%

+131.1%

+55.9%

+29.8%

+2.3%

OLP

Olaplex Holdings, Inc.

Peer

-91.7%

-47.8%

+63.2%

+65.8%

+63.2%

+0.5%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

21.5

18.4

1.94

2.04

2.23

3.0

34.01

$1.44B

Profitability

Profit margins and return metrics

Profit Margin 18.61%

Operating Margin -3.38%

Gross Margin 21.4%

ROE 10.53%

ROA 0.83%

Growth

Revenue and earnings growth rates

Revenue Growth -31.8%

Earnings Growth +1360.7%

Q/Q Revenue Growth -161.38%

Q/Q Earnings Growth +1348.6%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity

0.74

Moderate

Current Ratio

2.52

Strong

Quick Ratio

0.77

Poor

Cash/Share

$0.8

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue

$-0.1B

Gross Margin

38.9%

Op. Margin

42.6%

Net Margin

-58.4%

Total Assets

$1.5B

Liabilities

$0.8B

Equity

$0.7B

Debt/Equity

1.10x

Operating CF

$0.0B

CapEx

$-0.0B

Free Cash Flow

$0.0B

FCF Yield

89%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-04-30

$N/A

2026-02-26

$0.4

+81.0% surprise

2025-10-28

$0.61

+8.2% surprise

2025-07-29

$0.61

+26.8% surprise

Consumer Cyclical Sector Comparison

Comparing TRS against 291 companies in the Consumer Cyclical sector (17 bullish, 96 neutral, 178 bearish)

P/E Ratio

21.5

This Stock

33.44

Sector Avg

-35.7% (Discount)

Return on Equity (ROE)

10.53%

This Stock

-36.6%

Sector Avg

-128.8% (Below Avg)

Profit Margin

18.61%

This Stock

-5.76%

Sector Avg

-422.8% (Weaker)

Debt to Equity

0.74

This Stock

1.37

Sector Avg

-45.7% (Less Debt)

Revenue Growth

-31.8%

This Stock

14.09%

Sector Avg

-325.7% (Slower)

Current Ratio

2.52

This Stock

2.46

Sector Avg

+2.6% (Better)

Similar Companies

Peer comparison within the same industry

Company	AI Rating	Market Cap	P/E	ROE	Profit Margin	Price
TRS TriMas Corporation	NEUTRAL	$1.44B	21.5	10.5%	18.6%	$38.27
REAL The RealReal, Inc.	NEUTRAL	$1.44B	-	-%	-6.0%	$12.08	Compare
BH Biglari Holdings Inc.	BEARISH	$1.46B	217.27	0.4%	0.5%	$467.14	Compare
BH-A Biglari Holdings Inc.	BEARISH	$1.51B	227.28	0.4%	0.5%	$2434.13	Compare
OLPX Olaplex Holdings, Inc.	NEUTRAL	$1.37B	-	-1.1%	-2.2%	$2.04	Compare

TRS TriMas Corporation

NEUTRAL

Mkt Cap

$1.4B

P/E

21.5

ROE

10.5%

Price

$38.27

REAL The RealReal, Inc.

Compare with TRS

BH Biglari Holdings Inc.

Compare with TRS

BH-A Biglari Holdings Inc.

Compare with TRS

OLPX Olaplex Holdings, Inc.

Compare with TRS

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

Date	Insider	Position	Transaction	Shares	Value
2026-04-14	SEDAGHAT SHAWN	Director and Beneficial Owner of more than 10% of a Class of Security	Stock Award	640	$24,979
2026-03-13	SEDAGHAT SHAWN	Director and Beneficial Owner of more than 10% of a Class of Security	Stock Award	2,853	-
2026-03-13	TREDWELL DANIEL P	Director	Stock Award	2,853	-
2026-03-13	STANAGE NICKIE LEE	Director	Stock Award	2,853	-
2026-03-13	SWART PAUL	Chief Financial Officer	Stock Award	6,849	-
2026-03-13	SHAPIRA ADRIANNE	Director	Stock Award	2,853	-
2026-03-13	FINLEY TERESA M	Director	Stock Award	2,853	-
2026-03-13	BOEHNE HOLLY M	Director	Stock Award	2,853	-
2026-03-13	FIELKOW JEFFREY A	Director	Stock Award	2,853	-
2026-03-13	ROBIN JODI F	General Counsel	Stock Award	5,422	-
2026-03-13	PARKER HERBERT KENT	Director	Stock Award	2,853	-
2026-03-05	TREDWELL DANIEL P	Director	Purchase	59	$2,354
2025-12-31	SWART PAUL	Chief Financial Officer	Stock Award	7,052	-
2025-11-12	TREDWELL DANIEL P	Director	Purchase	73	$2,351
2025-11-11	FIELKOW JEFFREY A	Director	Purchase	2,000	$62,920

SEDAGHAT SHAWN

Director and Beneficial Owner of more than 10% of a Class of Security

Stock Award

2026-04-14

640 shares · $24,979

SEDAGHAT SHAWN

Director and Beneficial Owner of more than 10% of a Class of Security

Stock Award

2026-03-13

2,853 shares

TREDWELL DANIEL P

Director

Stock Award

2026-03-13

2,853 shares

STANAGE NICKIE LEE

Director

Stock Award

2026-03-13

2,853 shares

SWART PAUL

Chief Financial Officer

Stock Award

2026-03-13

6,849 shares

SHAPIRA ADRIANNE

Director

Stock Award

2026-03-13

2,853 shares

FINLEY TERESA M

Director

Stock Award

2026-03-13

2,853 shares

BOEHNE HOLLY M

Director

Stock Award

2026-03-13

2,853 shares

FIELKOW JEFFREY A

Director

Stock Award

2026-03-13

2,853 shares

ROBIN JODI F

General Counsel

Stock Award

2026-03-13

5,422 shares

PARKER HERBERT KENT

Director

Stock Award

2026-03-13

2,853 shares

TREDWELL DANIEL P

Director

Buy

2026-03-05

59 shares · $2,354

SWART PAUL

Chief Financial Officer

Stock Award

2025-12-31

7,052 shares

TREDWELL DANIEL P

Director

Buy

2025-11-12

73 shares · $2,351

FIELKOW JEFFREY A

Director

Buy

2025-11-11

2,000 shares · $62,920

Insider transactions can signal confidence or concerns about company prospects

SEC Filings

Recent regulatory filings from the SEC EDGAR database

DEF 14A

2026-03-31

TRS filed a Definitive Proxy Statement on March 31, 2026, providing shareholders with necessary information and voting materials for the company's annual meeting.

8-K

2026-03-18

8-K

2026-03-12

TRS filed an 8-K on March 12, 2026, likely to announce its annual financial results.

10-K

2026-03-02

TRS filed its annual 10-K on March 2, 2026, which includes disclosures regarding its business operations, risk factors, and management's discussion and analysis of financial condition. Specific financial highlights and risk details were not provided in the available excerpts.

8-K

2026-02-27

TRS filed an 8-K on February 27, 2026, likely to announce its annual financial results.

8-K

2026-02-26

TRS likely filed this 8-K to report its fourth-quarter and full-year financial results for the fiscal year ending 2025.

8-K

2025-12-04

8-K

2025-11-05

TRS filed an 8-K on November 5, 2025, likely to report third-quarter financial results or another material corporate event.

10-Q

2025-10-28

TRS submitted its quarterly 10-Q filing on October 28, 2025. While the document includes a section dedicated to Risk Factors, no specific financial highlights or detailed risk descriptions were provided in the available excerpt.

8-K

2025-10-28

TRS filed an 8-K on October 28, 2025, likely to report its third-quarter financial results.

10-Q

2025-07-29

8-K

2025-07-29

8-K

2025-06-09

8-K

2025-05-15

8-K

2025-04-29

Data sourced from SEC EDGAR. AI summaries generated automatically.

Wall Street Analysts

Professional analyst ratings and price targets

Consensus

NONE

2 analysts

BWS Financial

2026-03-02

Maintains

Buy Buy

BWS Financial

2025-12-05

Maintains

Buy Buy

Keybanc

2025-11-13

Maintains

Overweight Overweight

BWS Financial

2025-10-31

Maintains

Buy Buy

Past News Coverage

Recent headlines mentioning TRS from our newsroom.

Newest → oldest

Back to All Stocks

TradingGPT V2 Copilot

Fundamentals • Valuation • Risk

Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends

TRS

TRS TriMas Corporation - Fundamental Analysis

At a glance

AI Analysis

Key Strengths

Key Risks

Performance Snowflake

Stock Price & Analyst Targets

Multi-Horizon Performance vs Peers

Historical Performance Trends

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Valuation Metrics

Profitability

Growth

Financial Health

Financial Statement Flow

Quarterly Earnings History

Consumer Cyclical Sector Comparison

Similar Companies

Recent Insider Trading

SEC Filings

Wall Street Analysts

Past News Coverage

Wait — Don't Miss Out!